<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PRACE Archives - Pharmacelera | Pushing the limits of computational chemistry</title>
	<atom:link href="https://pharmacelera.com/blog/tag/prace/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description></description>
	<lastBuildDate>Wed, 08 Apr 2020 09:55:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://pharmacelera.com/wp-content/uploads/2022/04/cropped-Linkedin-avatar-32x32.png</url>
	<title>PRACE Archives - Pharmacelera | Pushing the limits of computational chemistry</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Free access to PharmScreen for COVID-19 research</title>
		<link>https://pharmacelera.com/blog/partnerships/covid-19-research-pharmscreen/</link>
		
		<dc:creator><![CDATA[Fernando Martín]]></dc:creator>
		<pubDate>Tue, 31 Mar 2020 07:13:53 +0000</pubDate>
				<category><![CDATA[Partnerships]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[free-access]]></category>
		<category><![CDATA[PharmScreen]]></category>
		<category><![CDATA[PRACE]]></category>
		<guid isPermaLink="false">https://new.pharmacelera.com/?p=6455</guid>

					<description><![CDATA[<p>The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 has spread to all countries without exception, affecting not only risk-population but [&#8230;]</p>
<p>The post <a href="https://pharmacelera.com/blog/partnerships/covid-19-research-pharmscreen/">Free access to PharmScreen for COVID-19 research</a> appeared first on <a href="https://pharmacelera.com">Pharmacelera | Pushing the limits of computational chemistry</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) or
COVID-19 has spread to all countries without exception, affecting not only risk-population
but also young people and healthy individuals. At Pharmacelera we want to join
the different public and private initiatives to find a treatment that can stop
the expansion of the virus.</p>



<p>To do so, we want to offer <strong>6-month
free access</strong> to all those researchers working on academia, public research
institutions, and non-profit organizations, who are creating novel<strong> small molecule strategies to stop the replication
of the virus</strong>.</p>



<h2 class="wp-block-heading"><strong>What type of access?</strong></h2>



<p>We will provide access to PharmScreen command-line and PharmScreen KNIME versions to run this software in your own IT equipment (Linux-based platform) free of charge.</p>



<p>If you do not have access to such an equipment, see Additional Help
section below.</p>



<h2 class="wp-block-heading"><strong>What can I do with PharmScreen? </strong></h2>



<div class="wp-block-image"><figure class="alignright size-large is-resized"><img fetchpriority="high" decoding="async" src="https://pharmacelera.com/wp-content/uploads/2020/03/covid-19-spike-protein.jpg" alt="covid-19 spike protein" class="wp-image-6462" width="301" height="330" srcset="https://pharmacelera.com/wp-content/uploads/2020/03/covid-19-spike-protein.jpg 643w, https://pharmacelera.com/wp-content/uploads/2020/03/covid-19-spike-protein-273x300.jpg 273w" sizes="(max-width: 301px) 100vw, 301px" /></figure></div>



<p><a href="https://pharmacelera.com/pharmscreen/">PharmScreen </a>is a ligand-based virtual screening tool that uses accurate hydrophobic molecular descriptors derived from Quantum-Mechanics (QM) calculations to perform searches in virtual libraries given one or more starting points (active ligand or fragment). Such a superior molecular representation helps mining a new chemical space and fits more original molecular candidates.  </p>



<p>We want to help researchers working on COVID-19 to expand the number  chemical series to the one they are proposing using structure-based  approaches on some of the virus targets, like SARS-CoV-2 spike protein  (PDB <a href="https://www.rcsb.org/structure/6vsb">6VSB</a>). PharmScreen will explore new chemical scaffolds based on  available chemical series. In addition, researchers can use PharmScreen  Scoring Function to re-evaluate docking poses, identifying additional  hits and helping to prioritize your lead compounds. </p>



<h2 class="wp-block-heading"><strong>What are my obligations?</strong></h2>



<p>Very few. You are fully entitled to use the software as much as you need within your entity and you will be the owner of all the intellectual property that may be generated from your work. Your only duties are to scope the applicability of this PharmScreen license to COVID-19 research and to reference it in any derived communication.</p>



<h2 class="wp-block-heading"><strong>What are the next steps?</strong></h2>



<p>Fill in the short form below and we will immediately contact you to grant you access.</p>



<h2 class="wp-block-heading"><strong>Additional help</strong></h2>



<p>If you are interested in this proposal but you lack some additional
support to perform your research, we can also help you in two different
aspects.</p>



<p>We can also help you providing computational chemistry services and advice if you do not have computational chemistry expertise or bandwidth. Although these services will not be free of charge, we will be flexible to adjust our fees to meet your needs.</p>



<p>As members of the Industrial Advisory Committee of <a href="https://prace-ri.eu/">PRACE</a>, we can help you requesting free simulation cycles from European supercomputers. Ask us about the open COVID-19 fast track.</p>



<p><iframe style="height:700px;width:99%;border:none;" src="https://forms.zohopublic.com/virtualoffice17604/form/Covid19/formperma/q6sobL_0KdvaM4MiW-KmznZn8H60FvVqtgTy7JE3xIk" frameborder="0"></iframe></p>
<p>The post <a href="https://pharmacelera.com/blog/partnerships/covid-19-research-pharmscreen/">Free access to PharmScreen for COVID-19 research</a> appeared first on <a href="https://pharmacelera.com">Pharmacelera | Pushing the limits of computational chemistry</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
